• Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)

Reta(for research use only)

No.001
What Is Reta?

Reta is a triple agonist peptide of the glucagon receptor (GCGR),glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1receptor.Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C.
For more details,please refer to the manual:Handling and Storage of Synthetic Peptides.
Product Details
Products Name: Reta
Purity: >99.0%
Molecular Formula: N/A
Molecular Weight: N/A
Application: Weight loss
Appearance: White powder
Reconstitution: Required
Storage:After reconstitution store at 2°C - 8°C
Specification: 5mg/vial;10mg/vial;15mg/vial;30mg/vial
Specifications:
2mg/vial,10vials/box
5mg/vial,10vials/box
10mg/vial,10vials/box
15mg/vial,10vials/box
30mg/vial,10vials/box
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)
  • Reta(for research use only)

Description


Application:


Reta were approved by the FDA for weight loss in late 2014. It's a newer class of drugs

better known for its ability to improve blood sugar control. These medications were actually

designed to treat type II diabetes,but some have also been FDA approved to treat weight

loss. The Multi-agonists we work with are called Smg& Tirz
.Tirze is a triple agonist peptide of

the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor

(GIPR), and
glucagon-like peptide-1 receptor. It showed glucose control and weight loss in

patients with type 2 diabetes mellitus (T2DM).
It can be used for the research of

obesity.
Normally, this peptide will be delivered in lyophilized form and should be stored in a

freezer at or below -20 °C. For more details,please refer to the manual:Handling and Storage

of Synthetic Peptides.